Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by N M Kröger
Monitoring of Minimal Residual Disease in Multiple Myeloma After Allo-Sct: Flow Cytometry vs PCR-based Techniques
Bone Marrow Transplantation
Transplantation
Hematology
Related publications
Flow Cytometry in the Diagnosis and Monitoring of Minimal Residual Disease in Multiple Myeloma
Oncogematologiya
Oncology
Hematology
Prospective Trial of Minimal Residual Disease Assessment by Multiparametric Flow Cytometry for Multiple Myeloma in the Era of Bortezomib-Based Chemotherapy
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Prospective Molecular Monitoring of Minimal Residual Disease After Non-Myeloablative Allografting in Newly Diagnosed Multiple Myeloma
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Minimal Residual Disease Testing After Stem Cell Transplantation for Multiple Myeloma
Bone Marrow Transplantation
Transplantation
Hematology
Minimal Residual Disease Assessment in the Context of Multiple Myeloma Treatment
Current Hematologic Malignancy Reports
Cancer Research
Oncology
Hematology
Prognostic Factors and Outcome in Relapsed Multiple Myeloma After Nonmyeloablative Allo-Sct: A Single Center Experience
Bone Marrow Transplantation
Transplantation
Hematology
Do Cytogenetics Predict Likelihood to Attain Minimal Residual Disease (MRD) Post Autologous Stem Cell Transplantation (SCT) in Multiple Myeloma (MM)?
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Comparative Analysis of Minimal Residual Disease Detection Using Four-Color Flow Cytometry, Consensus IgH-PCR, and Quantitative IgH PCR in CLL After Allogeneic and Autologous Stem Cell Transplantation
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Association of Minimal Residual Disease With Superior Survival Outcomes in Patients With Multiple Myeloma
JAMA Oncology
Cancer Research
Oncology
